Scinovex
Health Sciences → Medicine → Pharmacology

Treatment of Major Depression

This cluster of papers focuses on the molecular mechanisms and treatment strategies for depression, with a particular emphasis on antidepressant medications, ketamine, NMDA receptor antagonists, and neurobiological pathways. It covers topics such as treatment-resistant depression, glutamate signaling, cognitive impairment, and synaptic plasticity. The papers also discuss clinical guidelines and the evaluation of outcomes for various treatment approaches.

63.8K works worldwide1.4M citations
DepressionAntidepressantKetamineNMDA ReceptorTreatment-Resistant DepressionNeurobiological MechanismsGlutamate SignalingCognitive ImpairmentSynaptic PlasticityClinical Guidelines

Journals publishing in this area

Articles on Scinovex in this research area

3 articles, most cited first

  1. Serotonin transporter gene polymorphisms, 5-httlpr variants, and their association with major depressive disorder susceptibility
    International Journal of Advanced Biochemistry Research · 2025 · 0 citations
  2. Synaptic plasticity mechanisms underlying long-term potentiation in hippocampal CA1 neurons
    International Journal of Biology Sciences · 2025 · 0 citations · AI summary
  3. Biochemical analysis of neurotransmitter dysregulation in major depressive disorder: Integrating monoamine, inflammatory, and neuroendocrine biomarkers
    International Journal of Advanced Biochemistry Research · 2024 · 0 citations